Mesenchymal stem cells from patients with MS in interaction with autologous immune cells have defective immunomodulatory activity and enhance production of inflammatory cytokines

MULTIPLE SCLEROSIS JOURNAL

SAGE PUBLICATIONS LTD

1. MS Society of Great Britain and Northern Ireland
2. European Academy of Neurology